000 | 01784 a2200445 4500 | ||
---|---|---|---|
005 | 20250515052147.0 | ||
264 | 0 | _c20080109 | |
008 | 200801s 0 0 eng d | ||
022 | _a0167-6806 | ||
024 | 7 |
_a10.1007/s10549-006-9459-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHodges-Gallagher, Leslie | |
245 | 0 | 0 |
_aInhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. _h[electronic resource] |
260 |
_bBreast cancer research and treatment _cNov 2007 |
||
300 |
_a297-309 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAromatase _xmetabolism |
650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
650 | 0 | 4 |
_aEstrogen Receptor alpha _xgenetics |
650 | 0 | 4 |
_aEstrogens _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
650 | 0 | 4 |
_aHistone Deacetylases _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aTamoxifen _xantagonists & inhibitors |
650 | 0 | 4 |
_aUterus _xcytology |
650 | 0 | 4 |
_aValproic Acid _xpharmacology |
700 | 1 | _aValentine, Cathleen D | |
700 | 1 | _aBader, Suzy El | |
700 | 1 | _aKushner, Peter J | |
773 | 0 |
_tBreast cancer research and treatment _gvol. 105 _gno. 3 _gp. 297-309 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-006-9459-6 _zAvailable from publisher's website |
999 |
_c16753773 _d16753773 |